Cargando…

First MCL-1-selective BH3 mimetics as potential therapeutics for targeted treatment of cancer

Detalles Bibliográficos
Autores principales: Besbes, S, Billard, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650721/
https://www.ncbi.nlm.nih.gov/pubmed/26158516
http://dx.doi.org/10.1038/cddis.2015.168
_version_ 1782401545191555072
author Besbes, S
Billard, C
author_facet Besbes, S
Billard, C
author_sort Besbes, S
collection PubMed
description
format Online
Article
Text
id pubmed-4650721
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-46507212015-12-02 First MCL-1-selective BH3 mimetics as potential therapeutics for targeted treatment of cancer Besbes, S Billard, C Cell Death Dis News and Commentary Nature Publishing Group 2015-07 2015-07-09 /pmc/articles/PMC4650721/ /pubmed/26158516 http://dx.doi.org/10.1038/cddis.2015.168 Text en Copyright © 2015 Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ Cell Death and Disease is an open-access journal published by Nature Publishing Group. This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle News and Commentary
Besbes, S
Billard, C
First MCL-1-selective BH3 mimetics as potential therapeutics for targeted treatment of cancer
title First MCL-1-selective BH3 mimetics as potential therapeutics for targeted treatment of cancer
title_full First MCL-1-selective BH3 mimetics as potential therapeutics for targeted treatment of cancer
title_fullStr First MCL-1-selective BH3 mimetics as potential therapeutics for targeted treatment of cancer
title_full_unstemmed First MCL-1-selective BH3 mimetics as potential therapeutics for targeted treatment of cancer
title_short First MCL-1-selective BH3 mimetics as potential therapeutics for targeted treatment of cancer
title_sort first mcl-1-selective bh3 mimetics as potential therapeutics for targeted treatment of cancer
topic News and Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650721/
https://www.ncbi.nlm.nih.gov/pubmed/26158516
http://dx.doi.org/10.1038/cddis.2015.168
work_keys_str_mv AT besbess firstmcl1selectivebh3mimeticsaspotentialtherapeuticsfortargetedtreatmentofcancer
AT billardc firstmcl1selectivebh3mimeticsaspotentialtherapeuticsfortargetedtreatmentofcancer